nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—Galantamine—CHRNA4—attention deficit hyperactivity disorder	0.0367	1	CrCbGaD
Oxycodone—OPRD1—forebrain—attention deficit hyperactivity disorder	0.0356	0.116	CbGeAlD
Oxycodone—OPRK1—forebrain—attention deficit hyperactivity disorder	0.0341	0.111	CbGeAlD
Oxycodone—OPRM1—forebrain—attention deficit hyperactivity disorder	0.0243	0.0793	CbGeAlD
Oxycodone—OPRD1—nervous system—attention deficit hyperactivity disorder	0.0193	0.0631	CbGeAlD
Oxycodone—OPRD1—central nervous system—attention deficit hyperactivity disorder	0.0186	0.0608	CbGeAlD
Oxycodone—OPRK1—nervous system—attention deficit hyperactivity disorder	0.0185	0.0605	CbGeAlD
Oxycodone—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.0178	0.0582	CbGeAlD
Oxycodone—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.0174	0.0569	CbGeAlD
Oxycodone—OPRM1—midbrain—attention deficit hyperactivity disorder	0.016	0.0524	CbGeAlD
Oxycodone—OPRD1—brain—attention deficit hyperactivity disorder	0.0148	0.0482	CbGeAlD
Oxycodone—OPRK1—brain—attention deficit hyperactivity disorder	0.0142	0.0462	CbGeAlD
Oxycodone—OPRM1—nervous system—attention deficit hyperactivity disorder	0.0132	0.043	CbGeAlD
Oxycodone—OPRM1—central nervous system—attention deficit hyperactivity disorder	0.0127	0.0414	CbGeAlD
Oxycodone—OPRM1—brain—attention deficit hyperactivity disorder	0.0101	0.0329	CbGeAlD
Oxycodone—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00973	0.0318	CbGeAlD
Oxycodone—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00537	0.0175	CbGeAlD
Oxycodone—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00528	0.0173	CbGeAlD
Oxycodone—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00517	0.0169	CbGeAlD
Oxycodone—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00508	0.0166	CbGeAlD
Oxycodone—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00497	0.0162	CbGeAlD
Oxycodone—OPRD1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00426	0.00648	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00423	0.00644	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00419	0.00637	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00415	0.00631	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00415	0.00631	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00414	0.00629	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00408	0.00621	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00407	0.00619	CbGpPWpGaD
Oxycodone—CYP2D6—brain—attention deficit hyperactivity disorder	0.00404	0.0132	CbGeAlD
Oxycodone—OPRM1—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00401	0.00611	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00395	0.00602	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00389	0.00591	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00385	0.00586	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00385	0.00586	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00384	0.00584	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00378	0.00574	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00376	0.00573	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00374	0.00568	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00372	0.00567	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00369	0.00562	CbGpPWpGaD
Oxycodone—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00369	0.00561	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00367	0.00559	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00363	0.00552	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00358	0.00545	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00358	0.00544	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00358	0.00544	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00357	0.00543	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00351	0.00534	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00351	0.00533	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0035	0.00532	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00347	0.00528	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00341	0.00519	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00339	0.00515	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00338	0.00514	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00337	0.00512	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00333	0.00507	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.0033	0.00502	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00329	0.005	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00328	0.00499	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00325	0.00495	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00324	0.00493	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00319	0.00485	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00316	0.0048	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00314	0.00477	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.0031	0.00472	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00307	0.00467	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00307	0.00466	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00306	0.00466	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00303	0.0046	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00301	0.00459	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00297	0.00452	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00293	0.00446	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00292	0.00444	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00288	0.00439	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00288	0.00438	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00287	0.00437	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00287	0.00436	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00286	0.00435	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00285	0.00433	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00279	0.00424	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00274	0.00416	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00273	0.00415	CbGpPWpGaD
Oxycodone—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00273	0.00415	CbGpPWpGaD
Oxycodone—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00271	0.00412	CbGpPWpGaD
Oxycodone—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00269	0.00409	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00269	0.00409	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00267	0.00407	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00266	0.00405	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00265	0.00403	CbGpPWpGaD
Oxycodone—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00262	0.00399	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00259	0.00394	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00258	0.00393	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00254	0.00386	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00251	0.00382	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00251	0.00382	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0025	0.00381	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0025	0.00381	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00248	0.00377	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00247	0.00375	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00244	0.00371	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00243	0.0037	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00243	0.00369	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00239	0.00364	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00234	0.00357	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00234	0.00355	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00233	0.00355	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00227	0.00345	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00226	0.00344	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00222	0.00338	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0022	0.00334	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0022	0.00334	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00218	0.00332	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00217	0.00331	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00215	0.00327	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00213	0.00324	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00212	0.00323	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00205	0.00311	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00202	0.00308	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00198	0.00301	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00197	0.003	CbGpPWpGaD
Oxycodone—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00197	0.003	CbGpPWpGaD
Oxycodone—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00196	0.00298	CbGpPWpGaD
Oxycodone—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00194	0.00296	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00191	0.00291	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00191	0.00291	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00188	0.00286	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00188	0.00286	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00186	0.00282	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00186	0.00282	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00185	0.00282	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00184	0.00279	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0018	0.00274	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00173	0.00263	CbGpPWpGaD
Oxycodone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00171	0.00261	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.0017	0.00259	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00168	0.00256	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00163	0.00249	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00162	0.00247	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00162	0.00246	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00162	0.00246	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00159	0.00242	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00151	0.00229	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00149	0.00227	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00148	0.00224	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00147	0.00224	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00146	0.00223	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00146	0.00222	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00143	0.00218	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00143	0.00218	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00143	0.00218	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00142	0.00216	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00142	0.00215	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00141	0.00214	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.0014	0.00213	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00139	0.00212	CbGpPWpGaD
Oxycodone—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00138	0.0021	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00137	0.00209	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00137	0.00208	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00132	0.00201	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00132	0.00201	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00132	0.00201	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.0013	0.00198	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00129	0.00196	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00129	0.00196	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00128	0.00195	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00128	0.00195	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00126	0.00192	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00126	0.00191	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00126	0.00191	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00125	0.0019	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00124	0.00189	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00123	0.00188	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00121	0.00184	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.0012	0.00183	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0012	0.00182	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0012	0.00182	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00116	0.00177	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00116	0.00176	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00114	0.00174	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00113	0.00171	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00112	0.0017	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00112	0.0017	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00109	0.00166	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00108	0.00165	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00108	0.00164	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00106	0.00162	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00106	0.00162	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00105	0.0016	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00105	0.0016	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00104	0.00159	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00101	0.00154	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000994	0.00151	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000981	0.00149	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000977	0.00149	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000964	0.00147	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000953	0.00145	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000924	0.00141	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000917	0.00139	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00091	0.00138	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000904	0.00138	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000887	0.00135	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000871	0.00133	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000869	0.00132	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000839	0.00128	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00081	0.00123	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000808	0.00123	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000806	0.00123	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000782	0.00119	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00077	0.00117	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00077	0.00117	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000769	0.00117	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000762	0.00116	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000759	0.00116	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000758	0.00115	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000737	0.00112	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000735	0.00112	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000708	0.00108	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000707	0.00108	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000704	0.00107	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000686	0.00104	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000684	0.00104	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000674	0.00103	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000666	0.00101	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000644	0.000979	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000622	0.000946	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00062	0.000944	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000616	0.000937	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000599	0.000911	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000586	0.000892	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00058	0.000882	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000573	0.000872	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00057	0.000867	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000563	0.000856	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000557	0.000847	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000557	0.000847	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000548	0.000833	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000524	0.000798	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000509	0.000775	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000495	0.000754	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000467	0.00071	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000463	0.000705	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000445	0.000677	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000434	0.000661	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000424	0.000645	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000396	0.000602	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000396	0.000602	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000389	0.000592	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000375	0.00057	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000367	0.000559	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000362	0.000551	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000337	0.000513	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000335	0.000509	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000316	0.000481	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000301	0.000458	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000262	0.000399	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000259	0.000394	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000259	0.000394	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000255	0.000387	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.00024	0.000365	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000238	0.000362	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000237	0.00036	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00023	0.00035	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000207	0.000315	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	0.0002	0.000304	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000197	0.0003	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000195	0.000296	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000157	0.000239	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000156	0.000237	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	0.000145	0.00022	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000103	0.000156	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	6.72e-05	0.000102	CbGpPWpGaD
